NINA ANDERSON: Open Payments
NPI 1104918267 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,817 in 89 payments from 16 companies in 2025. Trend: 2023 $1,309 · 2024 $1,656 · 2025 $2,817
Food & beverage: $2,817
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 9 | $438 |
| E.R. Squibb & Sons, L.L.C. | 9 | $321 |
| Lundbeck LLC | 9 | $298 |
| Validus Pharmaceuticals LLC | 7 | $278 |
| Axsome Therapeutics, Inc. | 10 | $262 |
| Teva Pharmaceuticals USA, Inc. | 13 | $226 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $167 |
| Otsuka America Pharmaceutical, Inc. | 3 | $154 |
| Alkermes, Inc. | 7 | $141 |
| Noven Therapeutics, LLC | 1 | $125 |
Products named: REXULTI, FANAPT, COBENFY, EQUETRO, Auvelity, AUSTEDO XR, CAPLYTA, LYBALVI.
Industry payments across MI — which companies pay providers there.
